Global Markets on Infectious Diseases
Any discussion of the business case for infection control (IC) must start by acknowledging that the single most important reason for IC is to prevent morbidity and mortality associated with nosocomial infections. Each year, hundreds and thousands of Americans suffer the consequences of nosocomial infections which can be ranging from the inconvenience of taking extra medications to death. Beyond the human cost is the important economic burden that these infections place on society, including not only the obvious increase in health care resource use but also indirect costs associated with the loss of productivity of patients and their caregivers.
- Mechanism of action of virus
- Prevention and control of virus
- Rabies
- Malaria, Dengue fever, River blindness
- Available vaccines
Related Conference of Global Markets on Infectious Diseases
August 21-22, 2024
5th International conference on Vaccines, Vaccination and Immunization
Paris, France
September 12-13, 2024
19th International Conference on Allergy and Clinical Immunology
Paris, France
October 24-25, 2024
5th International Conference on Immunology And Immunotherapy
Zurich, Switzerland
Global Markets on Infectious Diseases Conference Speakers
Recommended Sessions
- Immunology of Infections
- Advancements in Vaccines and Therapeutics
- Antimicrobials/Antibiotics/Antibacterial
- Bacterial Infectious Diseases
- Blood infectious Diseases
- Dental and Oral Infectious Diseases
- Ebola and Zika Viral Infections
- Fungal Infectious Diseases
- Global Markets on Infectious Diseases
- HIV/AIDS and Sexually Transmitted Infections
- Infection Control And Public Health Awareness
- Infectious Diseases
- Infectious Diseases Epidemiology
- Molecular Diagnosis and Treatment of Infectious Diseases
- Most Common NTDs Causes and Treatments
- Neglected Tropical Diseases
- Neuro Infectious Diseases
- Nosocomial Infections & Control
- Pediatric Infectious Diseases
- Tropical Medicine and Immunization Vaccination
- Veterinary Infectious Diseases
- Viral Infectious Diseases
Related Journals
Are you interested in
- Advances in Molecular Immunology - ALLERGY 2024 (France)
- Allergen Identification and Characterization - ALLERGY 2024 (France)
- Biomarkers for Allergy Diagnosis and Treatment - ALLERGY 2024 (France)
- Case Studies in Allergy Diagnosis and Management - ALLERGY 2024 (France)
- Clinical Trials and Translational Research in Allergy and Immunology - ALLERGY 2024 (France)
- Digital Health and Telemedicine in Allergy Care - ALLERGY 2024 (France)
- Epidemiology and Population Studies in Allergic Diseases - ALLERGY 2024 (France)
- Immune Responses to Vaccination - ALLERGY 2024 (France)
- Immunogenetics and Allergic Susceptibility - ALLERGY 2024 (France)
- Immunological Aspects of Drug Allergies - ALLERGY 2024 (France)
- Immunological Basis of Food Allergy - ALLERGY 2024 (France)
- Immunological Mechanisms in Autoimmune Diseases - ALLERGY 2024 (France)
- Immunomodulation in Allergy Management - ALLERGY 2024 (France)
- Immunopathogenesis of Allergic Diseases - ALLERGY 2024 (France)
- Immunotherapy for Allergic Conditions - ALLERGY 2024 (France)
- Inflammatory Pathways in Asthma and Allergic Rhinitis - ALLERGY 2024 (France)
- Mechanisms of Immunodeficiency Diseases - ALLERGY 2024 (France)
- Novel Therapeutic Approaches for Allergic Disorders - ALLERGY 2024 (France)
- Role of Microbiota in Allergic Disorders - ALLERGY 2024 (France)